A Multicenter, Open-label, Phase I/II Dose Escalation and Expansion Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of YH003 in combination with Toripalimab (anti-PD-1mAb) in Subjects with Advanced Solid Tumors.

  • Markman, Ben (Primary Chief Investigator (PCI))
  • Hawkins, Cheryl-Ann (Project Manager)

Project: Research

Project Details

Effective start/end date20/10/2031/12/22


  • Medical oncology
  • Clinical trial